2 Weeks of Personalized Rehab Offered in New Wellness Program
A just-launched wellness program is offering a two-week, inpatient rehabilitation experience tailored to the needs of people with Parkinson’s…
Articles by Margarida Maia, PhD
Phase 2a Study of IkT-148009 Expected to Start Soon
Inhibikase expects to begin a Phase 2a study of IkT-148009, its investigational therapy for Parkinson’s disease, in the…
Ketamine Eases Levodopa-induced Dyskinesia in Phase 2 Study
Treatment with the low-dose painkiller ketamine eased levodopa-induced dyskinesia (uncontrollable body movements) in patients with Parkinson’s disease, according to results…
$2M Grant Awarded To Turn Immune Cells Into Dopaminergic Neurons
SQZ Biotechnologies has received a $2 million grant to work out a way to turn a patient’s own immune…
Skin Biopsy May Help Distinguish Parkinson’s From Similar Disorders
A form of the alpha-synuclein protein that can build up in the skin could help distinguish Parkinson’s disease from…
Excessive Sweating Can Affect Patients With Dyskinesia, Anxiety
Excessive sweating, known as hyperhidrosis, is fairly common among people with Parkinson’s and can worsen as the disease progresses,…
Machine Learning Can ID Patients by Voice, Distinguish Disease Stages
Machine learning — a form of artificial intelligence that allows a computer to adapt, analyze, and infer from patterns in…
Change Affecting Cell ‘Housekeeping’ Triggers Spread of Toxic Clumps
A protein modification that disrupts how cells dispose of “worn-out” proteins may promote the spread of the alpha-synuclein toxic clumps…
Study: SMARTfit May Outperform Traditional Physiotherapy
SMARTfit gym equipment, which combines movement with cognitive tasks in a playful way, may lead to better motor and cognitive…
GCase Mutations Prevent Clearing of Toxic Clumps, Treatment Possible
Mutations in the enzyme glucocerebrosidase (GCase) prevent it from entering the lysosome — a cell’s recycling center — where it clears…